Stephen B. Bratspies - Jan 28, 2025 Form 4 Insider Report for Hanesbrands Inc. (HBI)

Role: Chief Executive Officer, Director
Signature: /s/ Miranda Stephani, Attorney-in-Fact
Stock symbol: HBI
Transactions as of: Jan 28, 2025
Transactions value $: $0
Form type: 4
Date filed: 2/4/2025, 09:22 PM
Previous filing: Nov 21, 2024
Next filing: Jan 31, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HBI	Common Stock	Award	$0	+373K	+27.01%	$0.00	1.75M	Jan 28, 2025	Direct	F1
transaction	HBI	Common Stock	Award	$0	+159K	+9.05%	$0.00	1.91M	Jan 28, 2025	Direct	F2
holding	HBI	Common Stock						124K	Jan 28, 2025	By Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of restricted stock units that upon vesting are settled on a one-for-one basis in shares of common stock, vesting in three installments of 33% on January 28, 2026, 33% on January 28, 2027 and 34% on January 28, 2028.
F2	Consists of a performance share award ("PSA") granted to the Reporting Person on January 24, 2022. The number of shares of common stock that will be received upon vesting of the PSA was determined on January 28, 2025 based on the achievement of certain performance metrics during the fiscal years ended December 31, 2022, December 30, 2023 and December 28, 2024. The PSA will be settled on a one-for-one basis in shares of common stock on February 28, 2025.

Content

Consists of restricted stock units that upon vesting are settled on a one-for-one basis in shares of common stock, vesting in three installments of 33% on January 28, 2026, 33% on January 28, 2027 and 34% on January 28, 2028.

Consists of a performance share award ("PSA") granted to the Reporting Person on January 24, 2022. The number of shares of common stock that will be received upon vesting of the PSA was determined on January 28, 2025 based on the achievement of certain performance metrics during the fiscal years ended December 31, 2022, December 30, 2023 and December 28, 2024. The PSA will be settled on a one-for-one basis in shares of common stock on February 28, 2025.